Study to assess the safety, tolerability and pharmacokinetics and pharmacodynamics of AZD0284 in healthy subjects

Trial Identifier: D7800C00001
Sponsor:AstraZeneca
Collaborator:
PAREXEL
NCTID:NCT02976831
Start Date:December 2016
Primary Completion Date: May 2017
Study Completion Date: May 2017
Condition: Psoriasis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

LanguageDescription
English Translation
English Translation

Trial Locations

CountryLocation
United Kingdom London, United Kingdom, HA1 3UJ